Geopolitical trends, technological advances, and Nordic and European opportunities
Welcome to InLifeScience 2025 – a half-day conference that brings together actors from research, industry, and the investment community to strengthen preparedness and innovation within the life sciences in Norway and Europe.
The conference is organized in collaboration with The Life Science Cluster and this year it is free of charge.
Key areas in this year’s program:
- Geopolitical and regulatory trends
- Industry’s role in preparedness and supply security
- How to go from research to concrete solutions and value creation
- Future collaboration models across sectors and countries
- The role of artificial intelligence in accelerating drug development and strengthening healthcare systems
Through keynote talks, panel discussions, and parallell sessions, participants will gain insight, inspiration, and the chance to share their own perspectives and discover new collaboration and partnering opportunities.
Program
09:00 – 09:30: Registration and Coffee Informal networking and light refreshments
09:30 – 09:45: Welcome Delphine Costa presents the cluster and partners. Introduction and programme overview
09:45 – 10.30: Keynotes
09:45 – 10:05: Keynote 1
Transforming Drug Development Through AI
How can artificial intelligence fundamentally change the way we develop medicines? This keynote explores the digital transformation of drug development, showing how AI can streamline processes, reduce costs, and enable more precise and personalized treatments: from early-stage research to clinical trials and regulatory approval. The session will provide concrete examples of how AI supports smarter decision-making and accelerates the path from idea to patient.
Speaker: Petrina Kamya, VP, Global Head of AI Platforms, Insilico Medicine and President of Insilico Medicine, Canada
Join our pre-event with Dr. Petrina Kamya on 2 October – see The Life Science Clusters webpage
10:05 – 10:30: Keynote 2
Geopolitics, Trends, and European & Nordic Opportunities
What does today’s geopolitical landscape mean for life sciences in Europe and the Nordics? This keynote explores how global developments impact our ability to ensure innovation, supply security, and preparedness, along with which strategic opportunities are emerging for Nordic and European actors in the face of these changes.
Speaker: Rebekka Borsch, Director Research, Innovation and Digitalisation NHO
10:30 – 11:00: Investor Panel
At a time marked by geopolitical uncertainty, increased protectionism, and growing competition for technology and resources, investments in life sciences must also be viewed through a strategic lens. How do global power shifts and supply chain uncertainties affect investor priorities – and what role can Norway play as a stable, knowledge-based actor in the European ecosystem?
The panel will discuss access to capital, risk perspectives, and how we can build robust companies and platforms that both attract investment and strengthen Norway’s position in a changing geopolitical reality.
Panelists: Anne Ulvestad, Innosiamo, Founding Executive Director Founding Executive Director, More TBA
Moderator: Markus Dietrich, Phd, Senior Investment Associate, Hadean Ventures
11:00 – 11:45: Lunch Time for networking and lunch
11:45 – 12:45: Parallell Sessions
Pharmaceutics and Health
How do we ensure access to critical medicines – and who pays the bill?
This session highlights challenges related to preparedness, incentives, and compensation in the Norwegian healthcare system. Through a keynote and a follow-up conversation, we will gain insight into how industry and government can collaborate on solutions that benefit patients and strengthen supply security.
Opening presentation: Matthew Iles, General Manager AbbVie Scandinavia
Panelists: Matthew Iles, more TBA
Moderator: Jutta Heix, Head of International Affairs, Oslo Cancer Cluster
Bioresources and Sustainability
How can we use sustainable bioresources to strengthen Europe’s supply security and innovation ability? This session explores the role of political frameworks, industry, and the need for cross-sector collaboration. After an introductory presentation, participants are invited to join an open roundtable discussion with representatives from research, industry, and advocacy organizations.
Opening presentation: Øystein Arlov, Research Manager, SINTEF – Industry
Moderator: Benjamin Dyhre, Project Manager, The Life Science Cluster
12:45 – 13:15: Insight to Action
Collaborating to Strengthen Life Sciences in the Nordics – The Way Forward
The session presents insights into Sweden’s life science strategy and showcases collaboration between Testa Center, CCRM Nordic and NorthX Biologics, highlighting structural and financial foundations for growth and opportunities for Norwegian stakeholders. The session concludes with a dialogue on Nordic opportunities and challenges in life science preparedness.
13-.15-14:00 Cake, coffee, and networking
The organizers: The Life Science Cluster has 120 members within health and bioindustries. Established in 2016, the cluster has scored high on internationalization, member satisfaction and trust both between the members, and to the cluster administration. Its members covers the full five factor model with large and small companies, academia, investors and the public sector. With this as a base, how can Norwegian industry capitalize on regional and scientific strengths, to meet global needs in challenging times?
Tekna is a trade union for people with higher education within technology and natural sciences. Tekna Biotek is a professional network within Tekna focusing on biotechnology, molecular biology, chemistry, pharmacy, food and biochemistry, and has over 3900 members.
